L03.03PHASE I CLINICAL AND PHARMACOLOGICAL STUDY OF CETUGEX, A NOVEL ANTI-EGFR MONOCLONAL ANTIBODY WITH AN OPTIMIZED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY
2013
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI